Here are four quick facts:
1. The acquisition is projected to add around $4 million to Mesa’s revenues.
2. The majority of NBB’s business involves the testing of small table-top sterilizers in the U.S. dental industry.
3. NBB created a unique service in the sterilizer testing industry that tracks the performance of each sterilizer and enables the dental practice to monitor the data online.
4. NBB distributes self-contained biological indicators to dental markets in the United States and Canada for dentists who prefer to perform the testing process in-house.
More dental news:
Drs. Paula Palma, Philip Meeser & more: 6 dentists making headlines
3M acquires Capital Safety, Henry Schein shares rise 0.65% & more: 7 key notes
FDA clears 16 dental devices in July